drugset / Trial / NCT00336115

The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients

NCT00336115

Phase 4 Unknown 10 enrolled Queen Elizabeth II Health Sciences Centre
Non-randomizedSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to determine if pertussis (whooping cough) vaccine is safe and produces an appropriate immune response against pertussis in blood and marrow transplant patients.

Timeline

Start
2006-07
Primary completion
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Adacel Vaccine

Indications